PEPG SCHEDULE 13D/A: Insider sale planned
RA Capital Management and affiliated reporting persons
Filed with the SEC on · accession 0001346824-26-000301
PEPG filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Nov 17, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -7.4% by the first close after the filing.
Summary of the filing
RA Capital Management and affiliated reporting persons filed an amended Schedule 13D disclosing beneficial ownership of approximately 30.5% of PepGen Inc. following the Fund's purchase of 8,625,000 shares at $5.00 per share in the issuer's 2026 public offering.
Key details
How PEPG stock reacted
Close before
$4.19
Nov 16, 2026
First close after
-7.40%
$3.88
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for PEPG, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PEPG?
Click hereFrequently asked questions
What did PEPG file with the SEC on Nov 17, 2026?
PEPG filed a SCHEDULE 13D/A (Insider sale planned). RA Capital Management and affiliated reporting persons filed an amended Schedule 13D disclosing beneficial ownership of approximately 30.5% of PepGen Inc. following the Fund's purchase of 8,625,000 shares at $5.00 per share in the issuer's 2026 public offering.
How do I read a SCHEDULE 13D/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).
How did PEPG stock react to this filing?
PEPG closed at $4.19 before the filing and $3.88 on Nov 17, 2026 (-7.40%).
Other PEPG SEC filings
- 424B5 · Secondary offeringNov 12, 2026
- 8-K · Secondary offeringNov 12, 2026
- 10-Q · SEC filingNov 10, 2026
- 424B5 · Secondary offeringNov 10, 2026
- 8-K · Fda approvalNov 10, 2026
- 8-K · Fda approvalAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · Board changeJun 22, 2026
- 8-K · SEC filingMay 21, 2026
- S-3 · Shelf registrationMay 18, 2026
Get alerts when PEPG files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days